Search Results - "Ottanà, Rosaria"
-
1
Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions
Published in Journal of medicinal chemistry (12-03-2015)“…Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an enzyme crucially involved in the pathogenesis of chronic complications…”
Get full text
Journal Article -
2
Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine
Published in International journal of molecular sciences (01-06-2023)“…Protein tyrosine phosphatase 1B (PTP1B) is an enzyme crucially implicated in aberrations of various signaling pathways that underlie the development of…”
Get full text
Journal Article -
3
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors
Published in Bioorganic & medicinal chemistry letters (01-01-2011)“…2-Thioxo-4-thiazolidinone derivatives were evaluated as aldose reductase inhibitors (ARIs) and most of them exhibited good or excellent in vitro efficacy. Out…”
Get full text
Journal Article -
4
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14
Published in Bioorganic & medicinal chemistry letters (16-05-2005)“…The in vitro antimycobacterial activities of some isoniazid derivatives are reported. As a part of an ongoing search for new isoniazid-related…”
Get full text
Journal Article -
5
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I
Published in Bioorganic & medicinal chemistry letters (01-09-2005)“…The characterization of two cyclooxygenase isoforms (COX), the rate-limiting enzyme for the synthesis of prostaglandins (PGs) from arachidonic acid, has…”
Get full text
Journal Article -
6
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents
Published in Bioorganic & medicinal chemistry (01-07-2005)“…[Display omitted] The synthesis and pharmacological activity of 5-arylidene-2-imino-4-thiazolidinones ( 3a– 8a) are described. All derivatives exhibited…”
Get full text
Journal Article -
7
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives
Published in Bioorganic & medicinal chemistry (01-06-2008)“…In continuation of our studies, we here report a series of non-carboxylic acid containing 2,4-thiazolidinedione derivatives, analogues of previously…”
Get full text
Journal Article -
8
Sodium-Glucose Cotransporter Inhibitors as Antidiabetic Drugs: Current Development and Future Perspectives
Published in Journal of medicinal chemistry (25-08-2022)“…Sodium-glucose cotransporter 2 (SGLT-2) inhibitors (gliflozins) represent the most recently approved class of oral antidiabetic drugs. SGLT-2 overexpression in…”
Get full text
Journal Article -
9
Identification of new non-carboxylic acid containing inhibitors of aldose reductase
Published in Bioorganic & medicinal chemistry (01-06-2010)“…New non-carboxylic acid containing 5-arylidene-2,4-thiazolidinedione derivatives have been identified as aldose reductase inhibitors active at low micromolar…”
Get full text
Journal Article -
10
Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
Published in Bioorganic & medicinal chemistry letters (15-07-2007)“…A number of 5-arylidene-2,4-thiazolidinediones containing a hydroxy or a carboxymethoxy group in their 5-benzylidene moiety have been synthesised and evaluated…”
Get full text
Journal Article -
11
Structure–activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors
Published in Bioorganic & medicinal chemistry (15-04-2005)“…[Display omitted] The structure–activity relationships (SARs) of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors (ARIs) were extended…”
Get full text
Journal Article -
12
In Vitro Antimycobacterial Activities of 2′-Monosubstituted Isonicotinohydrazides and Their Cyanoborane Adducts
Published in Antimicrobial Agents and Chemotherapy (01-02-2002)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
13
5-Arylidene-4-thiazolidinone derivatives active as antidegenerative agents on human chondrocyte cultures
Published in Medicinal chemistry (Shp-sariqah, United Arab Emirates) (01-02-2013)“…5-Arylidene-2-oxo-4-thiazolidinones and 2-phenylimino analogues were evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by…”
Get more information
Journal Article -
14
In vitro aldose reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones
Published in Bioorganic & medicinal chemistry (15-01-2006)“…Several 5-benzyl-2,4-thiazolidinediones ( 5– 7) were synthesised and tested as in vitro aldose reductase (ALR2) inhibitors. Most of them, particularly…”
Get full text
Journal Article -
15
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones
Published in Bioorganic & medicinal chemistry letters (06-12-2004)“…The in vitro antimycobacterial activities of metalcomplexes 1, 2 are reported. The in vitro antimycobacterial activity of cobalt(II) and copper(II) complexes…”
Get full text
Journal Article -
16
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targets for the Design of Novel Therapeutic Agents
Published in Journal of medicinal chemistry (12-01-2012)Get full text
Journal Article -
17
Extending the investigation of 4-thiazolidinone derivatives as potential multi-target ligands of enzymes involved in diabetes mellitus and its long-term complications: A study with pancreatic α-amylase
Published in Carbohydrate research (01-01-2021)“…Diabetes mellitus is a multifactorial disease, which is frequently complicated by the development of hyperglycaemia-induced chronic complications. The therapy…”
Get full text
Journal Article -
18
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications
Published in Bioorganic & medicinal chemistry letters (15-12-2018)“…[Display omitted] •4-Thiazolidinones were synthesised and tested as dual AR/PTP1B inhibitors.•SAR, molecular docking and kinetic studies were carried out.•Two…”
Get full text
Journal Article -
19
Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors
Published in European journal of medicinal chemistry (05-04-2023)“…Type 2 diabetes mellitus (T2DM) is a serious chronic disease with an alarmingly growing worldwide prevalence. Current treatment of T2DM mainly relies on drug…”
Get full text
Journal Article -
20
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B
Published in Molecules (Basel, Switzerland) (10-01-2021)“…Diabetes mellitus (DM) is a complex disease which currently affects more than 460 million people and is one of the leading cause of death worldwide. Its…”
Get full text
Journal Article